Clinical & Diagnostic

Zidebactam/Cefepime (ZaynichTM) successful in renal transplant patient with extreme-drug resistant Pseudomonas infection

Promising treatment for extreme-drug resistant Pseudomonas infection in renal transplant patients"...

Apollo Hospital in New Delhi Initiates First Non-Invasive ZAP-X Brain Tumor Treatment in South Asia

Milestone Reinforces Mutual Commitment to Advancing Healthcare Through Greater Access to State-of-the-Art Medical Technologies...

Boston Scientific Receives FDA Approval for the AGENT™ Drug-Coated Balloon

First coronary drug-coated balloon in U.S. provides safe, effective alternative to treat coronary in-stent restenosis and reduce risk of reoccurrence...

Fujifilm unveils Echelon Synergy MRI Machine in India

A game-changer in healthcare technology with unparalleled performance...

Medidata and Sanofi Vaccine partners to enable remote patient monitoring with real-time data collection

The collaboration will deploy Medidata Electronic Clinical Outcomes Assessment (eCOA) to create an electronic diary database dedicated to Sanofi vaccines...

Medtronic announces expansion of Engineering & Innovation Center in Hyderabad

Medtronic Engineering and Innovation Center is Medtronic’s largest R&D centre outside the US...

KARL STORZ is First to Market with Alexa in the Operating Room

Voice-activated control in the surgical suite is designed to increase efficiency and patient focus....

“Early diagnosis through advanced screening tech, coupled with heightened awareness is crucial”

The oncology market in India is steadily growing, driven by an increasing cancer incidence and a strong demand for advanced treatments. However, there remains substantial untapped potential, primarily in improving access to cutting-edge therapies and expanding reach to underserved regions. Glenmark Pharma, with its patient-centric approach and innovative solutions, has been steadily increasing its market share by introducing high-quality and affordable cancer drugs. Alok Malik, President & ...